脊髓损伤的康复治疗体会

我院自1997年6月～2004年9月共收治脊髓损伤病人32例，现就其康复治疗体会报道如下。     

胰岛素强化治疗在2型糖尿病骨折患者围手术期的应用

Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation.     

缬沙坦治疗慢性心力衰竭73例疗效观察

缬沙坦是非肽类选择性血管紧张素Ⅱ(AngⅡ)1型受体(AT1)拮抗剂，本文对73例慢性充血性心力衰竭(CHF)患者用缬沙坦治疗，现将结果报告如下。     

全口义齿

全下颌种植覆盖总义齿塑料牙与瓷牙能量缓冲作用的比较分析；无牙颌患者不同垂直距离时下颌位置的研究；下颌磁性附着体覆盖全口义齿基牙龈沟内细菌的研究；不同舌翼肌功能整塑方法的舌侧基托边缘压痛发生率的比较研究；舌翼全口义齿与传统全口义齿满意度的比较；     

中药治疗化热型风湿关节炎40例临床观察

风寒湿邪侵入肌腠、经络、关节郁久化热的化热型风湿关节炎。笔者在临床中以芍药甘草汤合二妙散灵活加减，配以风湿膏外敷，通过40例临床观察，收效显著。     

综述列题

Apoptin-肿瘤基因治疗的新选择；BRLF1-EBV的一种立即早期基因的研究进展；E-选择素及其配体与肿瘤关系的研究进展；gp96与肿瘤免疫研究进展；IL-12抗肿瘤基因治疗的研究进展；p73基因与人类肿瘤的研究进展；RNA千扰技术的应用；Survivin基因及其与肿瘤靶向治疗；T淋巴瘤侵袭转移诱导因子1与肿瘤侵袭转移的研究进展；表皮生长因子受体信号通路及其靶向肿瘤治疗；单核苷酸多态性与肿瘤转移的关系；反应停抗肿瘤作用研究进展。[编者按]     

婴幼儿血管瘤应尽早治疗

血管瘤分为真性瘤和血管畸形，起源于残余的胚胎成血管细胞。血管瘤好发于婴幼儿．这是因为小儿皮肤内的微小血管的内皮细胞易发生异常增生所致。